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Abstract
Object To determine the single spin-echo T2 relaxation
times of uncoupled and J-coupled metabolites in rat brain
in vivo at 14.1 T and to compare these results with those
previously obtained at 9.4 T.
Materials and methods Measurements were performed
on five rats at 14.1 T using the SPECIAL sequence and TE-
specific basis-sets for LCModel analysis.
Results and conclusion The T2 of singlets ranged from 98
to 148 ms and T2 of J-coupled metabolites ranged from
72 ms (glutamate) to 97 ms (myo-inositol). When com-
paring the T2s of the metabolites measured at 14.1 T with
those previously measured at 9.4 T, a decreasing trend was
found (p \ 0.0001). We conclude that the modest short-
ening of T2 at 14.1 T has a negligible impact on the
sensitivity of the 1H MRS when performed at TE shorter
than 10 ms.
Keywords T2 relaxation time  Coupled spin systems 
Brain metabolites  Proton magnetic resonance localized
spectroscopy
Abbreviations
tCho Total choline (glycerophosphorylcholine ?
phosphorylcholine)
tCr Total creatine (phosphocreatine ? creatine)
Cr Creatine
GSH Glutathione
Glu Glutamate
Ins Myo-inositol
NAA N-acetylaspartate
Tau Taurine
VOI Volume of interest
SPECIAL SPin ECho, full Intensity Acquired Localized
spectroscopy
Introduction
In vivo 1H magnetic resonance spectroscopy (MRS) allows
for noninvasive investigations of neurochemical informa-
tion and thus has been widely used for studies of cerebral
diseases such as Alzheimer’s disease, schizophrenia, stroke
and others [1–3]. To preserve the maximum signal, a short
TE is preferable for minimizing signal loss due to T2
relaxation and signal modulation due to J-coupling. As an
alternative, a moderate/long TE is employed to eliminate
the confounding macromolecule signal from the 1H MR
spectra or to optimize the detection of specific metabolites
of interest [4]. At a moderate/long TE, quantification of
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J-coupled cerebral metabolites is possible when taking into
account the spectral shape modulation due to J-coupling,
and the signal loss due to T2 relaxation time.
The evaluation of the T2 relaxation time has been mostly
performed for singlet resonances such as that of the
N-acetylaspartate acetyl moiety (at 2.01 ppm), total crea-
tine (at 3.03 and 3.93 ppm) and choline-containing com-
pounds (at 3.2 ppm) [5, 6]. For J-coupled metabolite
resonances, the modulation with TE due to J-coupling
represents a confounding factor in the assessment of the
signal loss due to T2. In a previous study [7], the feasibility
of measuring T2 of J-coupled metabolites in rat brain at 9.4
T was demonstrated by using the LCModel [8] with TE-
specific basis sets, which take into account the signal
modulation due to J-coupling with TE. The same meth-
odology was further used for measuring T2 of J-coupled
metabolites in human brain at 3T [9], 4T [10] and 7T [11].
To achieve a higher sensitivity and spectral resolution in
1H MRS, the field strength (B0) of MR scanners is steadily
increasing, with an increasing number of scanners for
preclinical research being installed at B0 of 9.4 T and
higher. A significant reduction in the T2 values of proton
resonances (water, N-acetylaspartate, and total creatine)
has been observed with increasing magnetic field strength
and has been attributed mainly to increased dynamic
dephasing due to increased local susceptibility gradients
[12]. Since the quantitative contribution of different
relaxation mechanisms is not clearly understood in the
in vivo tissue, the relaxation times need to be determined
experimentally at these new field strengths. Therefore, the
current study carries a two-fold purpose: first, to determine
the single spin-echo T2 of uncoupled and J-coupled cere-
bral metabolites in rat brain in vivo at 14.1 T; second, to
compare these results with those obtained in the previous
study performed at 9.4 T [7].
Materials and methods
Animal and phantom preparation
In vivo MRS experiments were performed on five male
healthy Sprague Dawley rats (250–300 g), which were
anesthetized by 1.5–2 % isoflurane in oxygen during the
experiment. The animal was placed in a homebuilt holder
and the head was stereotaxically fixed by a bite bar and a
pair of ear bars. Respiration rate was monitored by a small
animal monitor (SA Instruments Inc., NY, USA) and
maintained at 70–100 breaths/min. The body temperature
was measured by a rectal thermosensor and maintained at
37.5 ± 0.5 C with the circulation of heated water. No
blood gas measurement was performed during the experi-
ment. All animal preparation procedures were performed
according to local and federal guidelines and the protocols
were approved by the local ethics committee.
In vivo MR experiments
All MRS experiments were carried out on a DirectDrive
MR spectrometer (Varian, Palo Alto, CA, USA) interfaced
to a 14.1 T, 26 cm horizontal bore magnet (Magnex Sci-
entific, Oxford, UK). A home-built 1H quadrature surface
coil consisting of two geometrically decoupled 14-mm-
diameter single loops was used as both a transmitter and
receiver.
In vivo 1H MR spectra were acquired from a VOI
(5 9 2.5 9 5 mm3) centered in the hippocampus, using a
spin-echo based full intensity localized pulse sequence
(SPECIAL [13]) with the following parameter settings:
TE = 2.8, 20, 40, 60, 80, 110, 130, 150, 170, 200, and
300 ms, TR = 4 s, spectral bandwith = 7 kHz, 4096
complex points and 10 FID data block each TE (16 aver-
ages/block). Spectra were acquired with increasing TEs
and total experiment lasted about 2 h. The VAPOR water
suppression technique [14] was applied in an interleaved
way with series of outer volume suppression pulses. The
static field inhomogeneity was optimized by first- and
second-order shims using echo-planar imaging-based
FASTMAP [15], which resulted in a water signal linewidth
of 16–19 Hz. For fitting peak intensities, high-SNR spectra
were used (the mean SNR of the N-acetylaspartate methyl
peak was *7 at the longest TE of 300 ms). In vitro 1H MR
spectra were acquired with a similar protocol on a phantom
containing creatine (50 mM) and glutamate (50 mM).
Data analysis
To determine the single spin-echo T2 of J-coupled metab-
olites, the J-modulation of the lineshapes was taken into
account by using LCModel with TE-specific basis sets that
were used for analyzing the spectra acquired at each TE
[7]. Nineteen metabolites (alanine, aspartate, c-aminobu-
tyric acid, glutamine, glutamate, glutathione, glycine, myo-
inositol, lactate, scyllo-inositol, taurine, ascorbate, glucose,
N-acetylaspartylglutamate, phosphorylethanolamine, glyc-
erophosphorylcholine, N-acetylaspartate, creatine and
phosphocreatine) were included in the basis sets and the
corresponding spectra were generated with density matrix
simulations [16], using published values of coupling con-
stants J and chemical shifts d [17] (T2 relaxation was not
included). Subspectra of the acetyl and aspartate moieties
of N-acetylaspartate (NAA), and the CH3 and CH2 groups
of total creatine (tCr), were prepared as separate compo-
nents in the basis sets for measuring T2 of individual
chemical groups in the same molecule. Macromolecule
spectra were obtained as previously described [18] and
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included as one component in the basis sets of each TE.
Metabolite concentrations obtained after the LCModel
quantification were fitted to a monoexponential function
using curve-fitting tool in Matlab (Version 7.1, The
MathWorks, Inc., Natick, MA, USA). The quality of the T2
fit was assessed by the coefficient of determination (R2).
Only the T2 of metabolite resonances with R
2 [ 0.95 are
reported here.
Results
In spectra measured in vitro, the singlet resonances of
creatine at 3.03 and 3.92 ppm decayed in amplitude with
increasing TE, while resonances of J-coupled metabolites
i.e., glutamate (Glu) displayed both a decrease in amplitude
and a modulation in their shape, e.g., the resonances at
2.34 ppm refocused at TE = 110 ms (data not shown).
Spectral modulations of glutamate were successfully
mimicked by spin simulations (data not shown), which
validates the accuracy of the spectral simulations.
In vivo water-suppressed 1H MR spectra and their cor-
responding LCModel fits show excellent correspondence
at different TEs (Fig. 1). The glutamate CH2 multiplet at
2.34 ppm and the myo-inositol (Ins) resonance peaks at
3.61 ppm developed from an absorption shape (at
TE = 2.8 ms) to a dispersion shape (at TE = 40 ms)
and then again to an absorption line appearance (at TE =
80/110 ms) (Fig. 1). The high SNR at 14.1 T allowed for
reliable measurement of tCr, total choline (tCho) and NAA
singlet resonance with CRLB\5 %, and Ins, taurine (Tau),
Glu and glutathione (GSH) with CRLB\30 % at most TEs.
Curve fitting of apparent concentrations for singlets
(NAA CH3 at 2.01 ppm) and J-coupled metabolites (Ins,
2.8 ms
20 ms
40 ms
60 ms
110 ms
80 ms
TE In vivo spectra LCModel fit
4.0 3.5 3.0 2.5 2.0
130 ms
170 ms
150 ms
300 ms
200 ms
4.0 3.5 3.0 2.5 2.0
Residual
×2
4.0 3.5 3.0 2.5 2.0 ppm
Fig. 1 A series of in vivo
spectra, the corresponding
LCModel fits and the fitting
residuals for TE ranging from
2.8 to 300 ms
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Glu) suggested that the decrease of signal intensities with
TE is largely described by a mono-exponential decay
(Fig. 2). The T2 of singlets ranged from 98 to 148 ms,
where the T2 of tCr (CH2) is the shortest for singlets and
the T2 of tCho (dominated by methyl group) is the longest.
For J-coupled cerebral metabolites, T2 ranged from 72 ms
(Glu) to 97 ms (Ins, Table 1).
When comparing the T2s of the metabolites measured at
14.1 T with those previously measured at 9.4 T [7], a
decreasing trend was found (p \ 0.0001, two-way
ANOVA) (Fig. 3). However, the decrease in T2 was rather
small (on average 10 %) except for NAA (30 %) and Ins
(38 %) (Fig. 3).
Discussion
The present study reports the T2 relaxation times of singlets
and J-coupled metabolites including NAA(CH3), tCr(CH3),
tCr(CH2), tCho, Ins, Glu, GSH and Tau at 14.1 T using
single spin-echo excitation and LCModel analysis with TE-
specific basis-sets.
Both in vitro and in vivo spectra (Fig. 1) demonstrated
that metabolites with singlet resonances decrease with TE
in spectral amplitude while J-coupled metabolites such as
Glu, vary with TE in both amplitude and spectral pattern.
When considering the spectral pattern modulation with TE
in the basis sets for LCModel analysis, the apparent con-
centration decays mono-exponentially with TE due to
signal loss of T2 relaxation time (Fig. 2), which allows for
the quantification of the T2 relaxation times of J-coupled
metabolites.
Since the signal intensity (i.e., the integral of resonance
peaks) varies with TE for J-coupled metabolites, spectra
measured at all TEs cannot be optimal for the T2 quanti-
fication of all metabolites. For instance, the signal intensity
of Glu and Ins peaks were close to zero around TE = 40,
60 ms and TE = 40, 130, 150 ms, respectively, which
might decrease the measurement accuracy. Therefore,
apparent concentrations obtained at those TEs in fit plots
(Fig. 2) demonstrate larger deviations from the fitting
curve. However, when excluding those spectra from the fit
data, the precision of the fit was improved, while no sub-
stantial difference was found for T2 values (within the fit-
ting error).
Data acquisition was performed with SPECIAL, which
is a localization method based on a single spin-echo
acquisition scheme. During the interpulse delay, magneti-
zation components could not be completely refocused by
the refocusing pulse due to dynamic dephasing induced by
diffusion in the inhomogeneous local magnetic field and
chemical exchange [12]. Therefore, signal loss increased
with the length of TE and thus reported T2 values in this
study were shorter than the intrinsic T2 relaxation times. T2
values of well-represented metabolites such as NAA(CH3),
tCr and tCho measured at 14.1 T in this study were shorter
than those reported at 4.7 [19], 9.4 and 11.7 T [6] in healthy
rat brain. The reduction of T2 relaxation times with
increasing magnetic field strength can be ascribed to the
increased loss of spin coherence due to molecular diffusion
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Fig. 2 Plots of the normalized apparent concentration as a function of TE of the NAA singlet, myo-inositol and glutamate at 14.1 T (circles) and
9.4 T (squares). Solid lines the exponential fit. Data points for 9.4T were taken from previously published study [7]
Table 1 T2 relaxation times (mean ± SD) of metabolites in rat brain
at 14.1 T
Metabolite T2 (ms) R
2
NAA(CH3) 142 ± 7 0.988
tCr(CH3) 107 ± 2 0.998
tCr(CH2) 98 ± 2 0.996
tCho 148 ± 14 0.958
Ins 97 ± 6 0.983
GSH 87 ± 13 0.948
Tau 82 ± 7 0.965
Glu 72 ± 8 0.958
R2 is the coefficient of determination (tCho total choline, NAA N-
acetylaspartate, tCr total creatine, Ins myo-inositol, GSH glutathione,
Tau taurine, Glu glutamate)
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across local magnetic field gradients, which are propor-
tional to the magnetic field strength. The contribution of
chemical exchange might be negligible for non-exchanging
protons of NAA(CH3), tCr and tCho.
The measured apparent T2 relaxation times vary with the
pulse sequence applied. The CPMG-type of sequence such
as LASER or CP-LASER suppresses signal dephasing and
results in a longer T2 values of metabolites compared to
PRESS or single spin-echo sequence [12]. In addition, the
local magnetic gradient could be altered by the level of
blood oxygenation due to different tissue composition and
physiology, which leads to the change in T2. For avoiding
the aforementioned concern in comparing T2 values at 14.1
T to those previously reported at 9.4 T, the measurement at
14.1 T was performed on an identical Varian INOVA
spectrometer using the same acquisition protocols (the
pulse sequence with the same RF pulses and TEs), RF
surface coils with the same shape and size, the VOI having
similar tissues composition, and the same data analysis
(LCModel fit with TE-specific basis-sets) as in the previous
measurement at 9.4 T. Although the blood gas was not
monitored during the experiment, the respiration rate was
maintained within the physiological range, the same way in
both 9.4 T and 14.1 T experiments. Therefore, T2 differ-
ence introduced by different degree of blood oxygenation
should be negligible and any deviations among individual
animals should be averaged out.
The modest decrease in T2s at 14.1 T compared to those
we previously reported at 9.4 T (Fig. 3) is consistent with
previous studies [6, 12]. The degree of T2 changes might
reflect different microenvironment or chemical exchange
contribution of individual metabolites, which leads to dif-
ferent degree of dynamic dephasing.
The decrease in T2 with increasing field strength can
impact the SNR increase that is gained when performing
MRS experiments at ultrahigh magnetic field. Note that
despite the shortened T2 at 14.1 T, the mean T2 of
metabolites (104 ms) at 14.1 T leads to a signal loss of
10 %, when using TE = 10 ms, which is within the bio-
logical variation. Therefore, the effect on the metabolite
quantification errors and SNR is expected to be negligible
when using a TE \10 ms.
For the quantitation of metabolites at a long TE, such as,
for example, in editing techniques [20] an internal refer-
ence (tCr methyl group) was sometimes employed when
assuming similar T2 impact on edited metabolites and the
internal reference. At 14.1 T, the difference in T2s of
J-coupled metabolites (Glu, Tau, Ins and GSH) and that of
the tCr methyl resonance should be taken into account
when tCr methyl peak is used as a reference in the quan-
tification of J-coupled metabolites using long-TE editing
technique.
Conclusion
We conclude that the T2 relaxation times of uncoupled and
coupled cerebral metabolites in rat brain at 14.1 T showed
a decreasing trend compared to 9.4 T, however, the impact
is negligible on the quantification of neurochemical profile
performed at short echo times.
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